Management of Moderate Chronic Kidney Disease

Classification and Significance

A GFR of 43 ml/min/1.73 m² indicates moderate chronic kidney disease (CKD stage 3b), representing a loss of more than half of normal adult kidney function, which increases the risk for complications, according to the American College of Physicians 1
This level of kidney function is classified as moderate chronic kidney disease (CKD stage 3) by the American Heart Association 2
The National Kidney Foundation classifies a GFR of 43 ml/min/1.73 m² as stage 3b CKD, which is the lower part of the 30-59 ml/min/1.73 m² range 3

The American College of Physicians recommends monitoring patients with GFR in the 30-59 ml/min/1.73 m² range and moderate albuminuria approximately 2 times per year 3
For patients with severe albuminuria (>300 mg/g creatinine), the American College of Physicians suggests increasing monitoring frequency to 3 times per year 3
The American Heart Association recommends regular assessment of GFR and albuminuria, as well as evaluation for progression and screening for complications of CKD, including hypertension, anemia, and metabolic abnormalities 1, 2

The American College of Cardiology recommends maintaining blood pressure ≤140/90 mmHg for patients with GFR 43 and urine albumin excretion <30 mg/24 hours 3
For patients with albuminuria ≥30 mg/24 hours, the American College of Cardiology suggests a lower target of ≤130/80 mmHg 3
The American Heart Association recommends using ACE inhibitors or ARBs as first-line agents, especially in the presence of albuminuria 3

The National Comprehensive Cancer Network recommends adjusting drug dosing based on reduced kidney function 4
The European Association for the Study of the Liver suggests avoiding nephrotoxic medications when possible 5

The American College of Physicians recommends dietary modifications, including sodium restriction and appropriate protein intake, for patients with CKD 1
The American Heart Association suggests regular physical activity as tolerated, smoking cessation, and weight management for those with obesity 1, 3

The American College of Physicians states that moderate CKD (GFR 30-59) is associated with increased risk of progression to kidney failure, cardiovascular disease, and all-cause mortality 1
The American Heart Association identifies risk factors for faster progression, including higher levels of albuminuria, hypertension, diabetes mellitus, and cardiovascular disease 3

The American Geriatrics Society notes that in elderly patients, a GFR of 43 still represents pathological reduction beyond normal aging 4
The European Association for the Study of the Liver recommends special attention for patients with cirrhosis and CKD, as standard nephroprotective strategies may be contraindicated 5, 6

The American College of Physicians recommends considering nephrology referral for all patients with GFR <45 ml/min/1.73 m² 3
The National Kidney Foundation suggests earlier referral for patients with rapid progression, persistent significant albuminuria, difficult to control hypertension, or complications of CKD that are difficult to manage 1, 3